Patents by Inventor Jeffrey Donald Turner

Jeffrey Donald Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
    Patent number: 9498544
    Abstract: The invention provides methods of preventing or treating diseases or disorders caused by biological agents or chemical agents in a subject (e.g., a mammal, such as a human) by administering genetically modified human umbilical cord perivascular cells.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: November 22, 2016
    Assignee: Tissue Regeneration Therapeutics Inc.
    Inventors: Jane Elizabeth Ennis, Jeffrey Donald Turner, John Edward Davies
  • GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS FOR PROPHYLAXIS AGAINST OR TREATMENT OF BIOLOGICAL OR CHEMICAL AGENTS
    Publication number: 20150182636
    Abstract: The invention provides methods of preventing or treating diseases or disorders caused by biological agents or chemical agents in a subject (e.g., a mammal, such as a human) by administering genetically modified human umbilical cord perivascular cells.
    Type: Application
    Filed: March 13, 2015
    Publication date: July 2, 2015
    Inventors: Jane Elizabeth ENNIS, Jeffrey Donald TURNER, John Edward DAVIES
  • Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
    Patent number: 9005599
    Abstract: The invention provides methods of preventing or treating diseases or disorders caused by biological agents or chemical agents in a subject (e.g., a mammal, such as a human) by administering genetically modified human umbilical cord perivascular cells.
    Type: Grant
    Filed: April 20, 2009
    Date of Patent: April 14, 2015
    Assignee: Tissue Regeneration Therapeutics Inc.
    Inventors: Jane Elizabeth Ennis, Jeffrey Donald Turner, John Edward Davies
  • GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS FOR PROPHYLAXIS AGAINST OR TREATMENT OF BIOLOGICAL OR CHEMICAL AGENTS
    Publication number: 20110177023
    Abstract: The invention provides methods of preventing or treating diseases or disorders caused by biological agents or chemical agents in a subject (e.g., a mammal, such as a human) by administering genetically modified human umbilical cord perivascular cells.
    Type: Application
    Filed: April 20, 2009
    Publication date: July 21, 2011
    Inventors: Jane Elizabeth Ennis, Jeffrey Donald Turner, John Edward Davies
  • Direct gene transfer into the ruminant mammary gland
    Patent number: 5780009
    Abstract: Disclosed is a method for expressing a heterologous gene in the mammary gland of a ruminant mammal. The invention is useful for producing a heterologous protein(s) in the milk of the mammal, for producing a heterologous enzyme(s) which is tethered to the mammary epithelial cell membrane and which can act on a component of the milk of the mammal, and for providing an antisense oligonucleotide(s) or ribozyme(s) which inhibits expression of a gene to a mammary epithelial cell. The method involves infusing a liquid complex including a genetic construct into a ductal tree of the mammal. The liquid complex can be infused before the mammal reaches sexual maturity and after the mammal develops a functional streak canal. Alternatively, a liquid complex that is free of live retroviruses can be infused. If desired, the infused genetic construct can be treated with a polycationic compound and/or a lipid to improve the efficiency with which it is taken up by an epithelial cell of the mammary gland.
    Type: Grant
    Filed: January 20, 1995
    Date of Patent: July 14, 1998
    Assignee: Nexia Biotechnologies, Inc.
    Inventors: Constantinos Karatzas, Anthoula Lazaris-Karatzas, Jeffrey Donald Turner